CRP and psychotic disorder: These beneficial effects can be explained by (i) the pathologic elevation of blood interleukin-6 and C-reactive protein levels in psychotic disorders (Delaney et al., 2019), and (ii) IFX’s ability to reduce these elevated levels (Brietzke and Kapczinski, 2008; Brietzke et al., 2009).